Jared C. Kelstrom

Real-world efficacy, safety, and usability of a microvolume eyedrop delivery device in glaucoma: prospective randomized crossover trial.

MD delivered with the Nanodropper adaptor provided additional IOP-L, significantly reduced PBE, and decreased the occurrence and severity of non-systemic AEs compared to CD in this cohort of stable POAG/OHT subjects.